Search

Search Results

• 

  28 | Efficacy and toxicity outcomes with doublet immunotherapy in metastatic melanoma: the real-world REALIPINIVO study Miriam Forte¹, Francesco Caraglia¹, Silvana Cozzolino¹, Antonino Colloca¹, Alfonso Esposito¹, Maria Cristina Giugliano¹, Eleonora Cioli¹, Marcella Scala², Francesca Sparano⁵, Maria Chiara Sergi³, Teresa Del Giudice⁴, Immacolata Paciolla⁶, Luigi Formisano², Stefania Napolitano¹, Antonio Maria Grimaldi⁶, Paolo Antonio Ascierto⁵, Fortunato Ciardiello¹, Teresa Troiani¹, Vincenzo De Falco¹ | ¹Medical Oncology, Department of Precision Medicine, Università degli Studi della Campania Luigi Vanvitelli, Naples; ²Department of Clinical Medicine and Surgery, Federico Il University, Naples; ³Unità Operativa Complessa di Oncologia Medica, Ospedale "Mons. A.R. Dimiccoli", Barletta; ⁴Nuclear Medicine Unit, "Mater Domini" University Hospital, Catanzaro; ⁵Istituto Nazionale Tumori IRCCS Fondazione Giovanni Pascale Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Napoli; ⁶Medical Oncology Unit AORN "San Pio", Benevento, Italy.

  Italian Melanoma Intergroup

  11-12-2025

  https://doi.org/10.4081/dr.2025.10770

  335
• 

  27 | Real-world data for malignant melanoma stage II adjuvant therapy Silvana Cozzolino¹, Antonino Colloca¹, Miriam Forte¹, Francesco Caraglia¹, Alfonso Esposito¹, Maria Cristina Giugliano¹, Eleonora Cioli¹, Marcella Scala², Maria Chiara Sergi³, Teresa Del Giudice⁴, Francesca Sparano⁵, Immacolata Paciolla⁶, Mariangela Pasqualoni⁷, Luigi Formisano², Stefania Napolitano¹, Antonio Maria Grimaldi¹, Paolo Antonio Ascierto⁵, Fortunato Ciardiello¹, Teresa Troiani¹, Vincenzo De Falco¹ | ¹Medical Oncology, Department of Precision Medicine, University of Campania "Luigi Vanvitelli", Naples; ²Department of Clinical Medicine and Surgery, University of Naples "Federico II", Naples, Italy; ³Division of Medical Oncology, "Mons. A.R. Dimiccoli" Hospital, Barletta; ⁴Nuclear Medicine Unit, "Mater Domini" University Hospital, Catanzaro; ⁵Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale, Naples; ⁶Medical Oncology Unit, AORN "San Pio", Benevento, Italy; ⁷Medical Oncology Unit, ASL Taranto, Italy.

  Italian Melanoma Intergroup

  11-12-2025

  https://doi.org/10.4081/dr.2025.10769

  336